WHO Warns: Expect More TB Cases and Deaths Worldwide
The WHO stated that although more than 79 million lives have been saved from tuberculosis since 2000 due to anti-TB efforts, severe budget reductions now pose a risk of undoing these advancements.
Each year, at least one million individuals worldwide receive a tuberculosis diagnosis. In Kenya specifically, approximately 97,000 cases of TB were identified in 2024.
TB is the most lethal infectious disease globally.
In a press release, Dr. Tedros Adhanom Ghebreyesus, the World Health Organization’s Director-General stated: “Over the last two decades, significant progress was achieved globally against tuberculosis; however, these advancements are currently endangered due to budget reductions which hinder individuals’ access to essential preventive measures, screenings, and therapeutic treatments for TB,” he emphasized. “Nonetheless, we must not abandon the firm pledges that global leaders reaffirmed less than one year and a half ago during the United Nations General Assembly aimed at intensifying efforts towards eradicating TB altogether.”
WHO is dedicated to collaborating with every donor, partner, and nation impacted to lessen the effects of budget reductions and discover creative answers.
The WHO indicated that significant interruptions in tuberculosis treatment have been observed across many of the highest-burden countries due to funding reductions.
The highest impact of this issue is being felt by countries within the WHO African Region, closely trailed by those in the WHO South-East Asia and Western Pacific regions. A total of twenty-seven nations are grappling with severe disruptions in their tuberculosis control efforts, leading to dire outcomes.
The WHO also stated that the planned funding reductions for 2025 will worsen an already insufficient financial situation for the worldwide tuberculosis response. In 2023, merely 26% of the required $22 billion yearly budget for TB prevention and treatment was secured, resulting in a significant gap. The state of TB research is dire, having received only one-fifth of the targeted $5 billion in 2022—a shortage that has significantly impeded progress in developing new diagnostic tools, therapies, and vaccines.
In her statement, Dr Tereza Kasaeva, who leads WHO’s Global Programme on TB and Lung Health, remarked, “This critical appeal comes at an essential time and highlights the importance of rapid and firm actions to maintain global advancements against tuberculosis and avoid reversals that might claim lives.”
She stated, “Allocating resources to combat TB is both a ethical duty and an economic must—a reported $43 in economic benefits is generated for every dollar invested inTB prevention and treatment.”
The increase in drug-resistant strains of tuberculosis, particularly throughout Europe, along with the continuous conflicts in the Middle East, Africa, and Eastern Europe, has intensified the challenges faced by the most susceptible populations in their battle against this disease.
The WHO is spearheading initiatives to speed up the development of a TB vaccine via the TB Vaccine Accelerator Council; however, advancements could be jeopardized without immediate financial support.
Provided by Syndigate Media Inc. (
Syndigate.info
).
